Literature DB >> 21736622

Prevalence of hypertrophic cardiomyopathy in a cohort of British Shorthair cats in Denmark.

S Granström1, M T Nyberg Godiksen, M Christiansen, C B Pipper, J L Willesen, J T Willesen, J Koch.   

Abstract

BACKGROUND: Familial hypertrophic cardiomyopathy (HCM) has been described previously in British Shorthair cats (BSH), but until now, no reports have been published describing the prevalence of the disease within this breed.
OBJECTIVES: The aim of this study was to assess the prevalence of HCM in a large cohort of BSH and to evaluate the effect of sex, weight, and increasing age as potential risk factors for this disease. ANIMALS: Three hundred and twenty-nine BSH presented for routine HCM screening during a 4-year period.
METHODS: Prospective cross-sectional study in which all cats were screened for HCM by conventional echocardiography.
RESULTS: A total of 329 cats were examined, 214 females and 115 males, with a median age of 2.3 years (range, 0.8-14.1). Twenty-eight cats (8.5%) were classified as HCM-positive, 14 (4.3%) as equivocal, 282 (85.7%) as HCM-negative, and 5 (2.1%) were diagnosed with other cardiac diseases. The median age for diagnosis of HCM was 2.7 years (range, 0.9-14.1). Male cats had a significantly higher occurrence of HCM (20.4%) compared with the females (2.1%) corresponding to an odds ratio of 7.89 (95 % CI, 2.54-28.08) for males versus females adjusted for age and weight (P < .001).
CONCLUSION: The BSH in our cohort had a high prevalence of HCM, often of early onset and with a significant male sex predisposition. We strongly recommend echocardiographic screening in this breed, especially cats used for breeding.
Copyright © 2011 by the American College of Veterinary Internal Medicine.

Entities:  

Mesh:

Year:  2011        PMID: 21736622     DOI: 10.1111/j.1939-1676.2011.0751.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  15 in total

Review 1.  Human heart failure with preserved ejection versus feline cardiomyopathy: what can we learn from both veterinary and human medicine?

Authors:  Valentine Prat; Bertrand Rozec; Chantal Gauthier; Benjamin Lauzier
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

2.  Assessment of left ventricular longitudinal function in cats with subclinical hypertrophic cardiomyopathy using tissue Doppler imaging and speckle tracking echocardiography.

Authors:  Keisuke Sugimoto; Yoko Fujii; Hiroshi Sunahara; Takuma Aoki
Journal:  J Vet Med Sci       Date:  2015-04-16       Impact factor: 1.267

3.  Tissue-specific and substrate-specific mitochondrial bioenergetics in feline cardiac and skeletal muscles.

Authors:  Liselotte Bruun Christiansen; Flemming Dela; Jørgen Koch; Takashi Yokota
Journal:  J Vet Med Sci       Date:  2015-03-11       Impact factor: 1.267

4.  Health and Behavioral Survey of over 8000 Finnish Cats.

Authors:  Katariina Vapalahti; Anna-Maija Virtala; Tara A Joensuu; Katriina Tiira; Jaana Tähtinen; Hannes Lohi
Journal:  Front Vet Sci       Date:  2016-08-29

5.  International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: The REVEAL Study.

Authors:  Philip R Fox; Bruce W Keene; Kenneth Lamb; Karsten A Schober; Valerie Chetboul; Virginia Luis Fuentes; Gerhard Wess; Jessie Rose Payne; Daniel F Hogan; Alison Motsinger-Reif; Jens Häggström; Emilie Trehiou-Sechi; Deborah M Fine-Ferreira; Reid K Nakamura; Pamela M Lee; Manreet K Singh; Wendy A Ware; Jonathan A Abbott; Geoffrey Culshaw; Sabine Riesen; Michele Borgarelli; Michael B Lesser; Nicole Van Israël; Etienne Côté; John E Rush; Barret Bulmer; Roberto A Santilli; Andrea C Vollmar; Maribeth J Bossbaly; Nadine Quick; Claudio Bussadori; Janice M Bright; Amara H Estrada; Dan G Ohad; Maria Josefa Fernández-Del Palacio; Jenifer Lunney Brayley; Denise S Schwartz; Christina M Bové; Sonya G Gordon; Seung Woo Jung; Paola Brambilla; N Sydney Moïse; Christopher D Stauthammer; Rebecca L Stepien; Cecilia Quintavalla; Christophe Amberger; Ferenc Manczur; Yong-Wei Hung; Remo Lobetti; Marie De Swarte; Alice Tamborini; Carmel T Mooney; Mark A Oyama; Andrey Komolov; Yoko Fujii; Romain Pariaut; Masami Uechi; Victoria Yukie Tachika Ohara
Journal:  J Vet Intern Med       Date:  2018-04-16       Impact factor: 3.333

6.  Evaluation of a sensitive cardiac troponin I assay as a screening test for the diagnosis of hypertrophic cardiomyopathy in cats.

Authors:  S Hertzsch; A Roos; G Wess
Journal:  J Vet Intern Med       Date:  2019-04-16       Impact factor: 3.333

7.  Cardiac troponin I and T as prognostic markers in cats with hypertrophic cardiomyopathy.

Authors:  R Langhorn; I Tarnow; J L Willesen; M Kjelgaard-Hansen; I M Skovgaard; J Koch
Journal:  J Vet Intern Med       Date:  2014-07-23       Impact factor: 3.333

8.  Effect of Body Weight on Echocardiographic Measurements in 19,866 Pure-Bred Cats with or without Heart Disease.

Authors:  J Häggström; Å O Andersson; T Falk; L Nilsfors; U OIsson; J G Kresken; K Höglund; M Rishniw; A Tidholm; I Ljungvall
Journal:  J Vet Intern Med       Date:  2016-08-30       Impact factor: 3.333

9.  Reference intervals and allometric scaling of two-dimensional echocardiographic measurements in 150 healthy cats.

Authors:  Schober Karsten; Savino Stephanie; Yildiz Vedat
Journal:  J Vet Med Sci       Date:  2017-10-06       Impact factor: 1.267

10.  Effects of atenolol on left atrial and left ventricular function in healthy cats and in cats with hypertrophic cardiomyopathy.

Authors:  Keisuke Sugimoto; Takuma Aoki; Yoko Fujii
Journal:  J Vet Med Sci       Date:  2020-03-19       Impact factor: 1.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.